FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2162415186> ?p ?o ?g. }

• W2162415186 endingPage "e107461" @default.
• W2162415186 startingPage "e107461" @default.
• W2162415186 abstract "Age-related macular degeneration (AMD) is the leading cause of severe vision impairment in Western populations over 55 years. A growing number of gene variants have been identified which are strongly associated with an altered risk to develop AMD. Nevertheless, gene-based biomarkers which could be dysregulated at defined stages of AMD may point toward key processes in disease mechanism and thus may support efforts to design novel treatment regimens for this blinding disorder. Circulating microRNAs (cmiRNAs) which are carried by nanosized exosomes or microvesicles in blood plasma or serum, have been recognized as valuable indicators for various age-related diseases. We therefore aimed to elucidate the role of cmiRNAs in AMD by genome-wide miRNA expression profiling and replication analyses in 147 controls and 129 neovascular AMD patients. We identified three microRNAs differentially secreted in neovascular (NV) AMD (hsa-mir-301-3p, pcorrected = 5.6*10−5, hsa-mir-361-5p, pcorrected = 8.0*10−4 and hsa-mir-424-5p, pcorrected = 9.6*10−3). A combined profile of the three miRNAs revealed an area under the curve (AUC) value of 0.727 and was highly associated with NV AMD (p = 1.2*10−8). To evaluate subtype-specificity, an additional 59 AMD cases with pure unilateral or bilateral geographic atrophy (GA) were analyzed for microRNAs hsa-mir-301-3p, hsa-mir-361-5p, and hsa-mir-424-5p. While we found no significant differences between GA AMD and controls neither individually nor for a combined microRNAs profile, hsa-mir-424-5p levels remained significantly higher in GA AMD when compared to NV (pcorrected<0.005). Pathway enrichment analysis on genes predicted to be regulated by microRNAs hsa-mir-301-3p, hsa-mir-361-5p, and hsa-mir-424-5p, suggests canonical TGFβ, mTOR and related pathways to be involved in NV AMD. In addition, knockdown of hsa-mir-361-5p resulted in increased neovascularization in an in vitro angiogenesis assay." @default.
• W2162415186 created "2016-06-24" @default.
• W2162415186 creator A5000233062 @default.
• W2162415186 creator A5000411640 @default.
• W2162415186 creator A5007529353 @default.
• W2162415186 creator A5033338552 @default.
• W2162415186 creator A5058056443 @default.
• W2162415186 creator A5059517063 @default.
• W2162415186 creator A5068258073 @default.
• W2162415186 creator A5077993009 @default.
• W2162415186 creator A5078548441 @default.
• W2162415186 creator A5088802809 @default.
• W2162415186 creator A5088887546 @default.
• W2162415186 date "2014-09-09" @default.
• W2162415186 modified "2023-10-16" @default.
• W2162415186 title "A Circulating MicroRNA Profile Is Associated with Late-Stage Neovascular Age-Related Macular Degeneration" @default.
• W2162415186 cites W1487528435 @default.
• W2162415186 cites W180947891 @default.
• W2162415186 cites W1966566182 @default.
• W2162415186 cites W1967951903 @default.
• W2162415186 cites W1970482292 @default.
• W2162415186 cites W1989910375 @default.
• W2162415186 cites W2003816656 @default.
• W2162415186 cites W2011188823 @default.
• W2162415186 cites W2025544830 @default.
• W2162415186 cites W2035113359 @default.
• W2162415186 cites W2035310463 @default.
• W2162415186 cites W2036910617 @default.
• W2162415186 cites W2038713393 @default.
• W2162415186 cites W2052064127 @default.
• W2162415186 cites W2052142983 @default.
• W2162415186 cites W2073461896 @default.
• W2162415186 cites W2081113032 @default.
• W2162415186 cites W2094173563 @default.
• W2162415186 cites W2094753668 @default.
• W2162415186 cites W2099989980 @default.
• W2162415186 cites W2104421727 @default.
• W2162415186 cites W2107665951 @default.
• W2162415186 cites W2127439967 @default.
• W2162415186 cites W2129802808 @default.
• W2162415186 cites W2131523986 @default.
• W2162415186 cites W2141138739 @default.
• W2162415186 cites W2147495091 @default.
• W2162415186 cites W2155323171 @default.
• W2162415186 cites W2160198513 @default.
• W2162415186 cites W2162618225 @default.
• W2162415186 cites W2166164651 @default.
• W2162415186 cites W3009740494 @default.
• W2162415186 cites W4365808297 @default.
• W2162415186 doi "https://doi.org/10.1371/journal.pone.0107461" @default.
• W2162415186 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4159338" @default.
• W2162415186 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25203061" @default.
• W2162415186 hasPublicationYear "2014" @default.
• W2162415186 type Work @default.
• W2162415186 sameAs 2162415186 @default.
• W2162415186 citedByCount "62" @default.
• W2162415186 countsByYear W21624151862015 @default.
• W2162415186 countsByYear W21624151862016 @default.
• W2162415186 countsByYear W21624151862017 @default.
• W2162415186 countsByYear W21624151862018 @default.
• W2162415186 countsByYear W21624151862019 @default.
• W2162415186 countsByYear W21624151862020 @default.
• W2162415186 countsByYear W21624151862021 @default.
• W2162415186 countsByYear W21624151862022 @default.
• W2162415186 countsByYear W21624151862023 @default.
• W2162415186 crossrefType "journal-article" @default.
• W2162415186 hasAuthorship W2162415186A5000233062 @default.
• W2162415186 hasAuthorship W2162415186A5000411640 @default.
• W2162415186 hasAuthorship W2162415186A5007529353 @default.
• W2162415186 hasAuthorship W2162415186A5033338552 @default.
• W2162415186 hasAuthorship W2162415186A5058056443 @default.
• W2162415186 hasAuthorship W2162415186A5059517063 @default.
• W2162415186 hasAuthorship W2162415186A5068258073 @default.
• W2162415186 hasAuthorship W2162415186A5077993009 @default.
• W2162415186 hasAuthorship W2162415186A5078548441 @default.
• W2162415186 hasAuthorship W2162415186A5088802809 @default.
• W2162415186 hasAuthorship W2162415186A5088887546 @default.
• W2162415186 hasBestOaLocation W21624151861 @default.
• W2162415186 hasConcept C104317684 @default.
• W2162415186 hasConcept C118487528 @default.
• W2162415186 hasConcept C126322002 @default.
• W2162415186 hasConcept C143998085 @default.
• W2162415186 hasConcept C145059251 @default.
• W2162415186 hasConcept C150194340 @default.
• W2162415186 hasConcept C18431079 @default.
• W2162415186 hasConcept C20518536 @default.
• W2162415186 hasConcept C2776403814 @default.
• W2162415186 hasConcept C2779134260 @default.
• W2162415186 hasConcept C2781197716 @default.
• W2162415186 hasConcept C2781359195 @default.
• W2162415186 hasConcept C2991880128 @default.
• W2162415186 hasConcept C54355233 @default.
• W2162415186 hasConcept C60644358 @default.
• W2162415186 hasConcept C71924100 @default.
• W2162415186 hasConcept C86803240 @default.
• W2162415186 hasConceptScore W2162415186C104317684 @default.
• W2162415186 hasConceptScore W2162415186C118487528 @default.
• W2162415186 hasConceptScore W2162415186C126322002 @default.

• next